Northern Trust
BNGO icon

Northern Trust’s Bionano Genomics BNGO Stock Holding History

Northern Trust’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.8K Buy
24,561
+4,042
+20% +$4.87K ﹤0.01% 4341
2026
Q1 		$24K Hold
20,519
– – ﹤0.01% 4320
2025
Q4 		$31.4K Buy
+20,519
New +$35.5K ﹤0.01% 4344
2025
Q1 		– Sell
-2,269
Closed -$39.3K – 4429
2024
Q4 		$39.3K Sell
2,269
-183
-7% -$3.13K ﹤0.01% 4293
2024
Q3 		$66.8K Hold
2,452
– – ﹤0.01% 4152
2024
Q2 		$99.8K Buy
2,452
+666
+37% +$36.6K ﹤0.01% 4055
2024
Q1 		$119K Sell
1,786
-52
-3% -$3.88K ﹤0.01% 4031
2023
Q4 		$208K Buy
1,838
+581
+46% +$60.7K ﹤0.01% 3887
2023
Q3 		$229K Buy
1,257
+296
+31% +$77.6K ﹤0.01% 3758
2023
Q2 		$352K Sell
961
-3,437
-78% -$1.55M ﹤0.01% 3631
2023
Q1 		$2.93M Sell
4,398
-175
-4% -$155K ﹤0.01% 2766
2022
Q4 		$4.01M Buy
4,573
+175
+4% +$220K ﹤0.01% 2618
2022
Q3 		$4.83M Buy
4,398
+15
+0.3% +$19.8K ﹤0.01% 2504
2022
Q2 		$3.63M Sell
4,383
-223
-5% -$229K ﹤0.01% 2711
2022
Q1 		$7.13M Sell
4,606
-123
-3% -$166K ﹤0.01% 2358
2021
Q4 		$8.48M Buy
4,729
+143
+3% +$382K ﹤0.01% 2352
2021
Q3 		$15.1M Buy
4,586
+2,716
+145% +$9.5M ﹤0.01% 1990
2021
Q2 		$8.22M Buy
1,870
+1,277
+215% +$5.04M ﹤0.01% 2506
2021
Q1 		$2.88M Buy
593
+113
+24% +$637K ﹤0.01% 3056
2020
Q4 		$887K Buy
480
+243
+103% +$90.8K ﹤0.01% 3557
2020
Q3 		$93K Buy
237
+134
+130% +$52K ﹤0.01% 3979
2020
Q2 		$32K Buy
103
+61
+145% +$15.3K ﹤0.01% 4106
2020
Q1 		$11K Buy
42
+19
+83% +$10.7K ﹤0.01% 4142
2019
Q4 		$17K Buy
+23
New +$13.4K ﹤0.01% 4170

Other funds holding BNGO

GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
CAM
Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
EGM
Engineers Gate Manager New York $7.71B AUM 24.88% 1-Year Est. Return

Northern Trust's BNGO Position: Q2 2026 in Review

Northern Trust increased its Bionano Genomics (BNGO) stake by 20% in Q2 2026, buying an estimated $4.87K and bringing the position to 24,561 shares worth $27.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4341.

Northern Trust first reported a position in BNGO in Q4 2019 and has held it in 24 quarters since. The position peaked at $15.1M in Q3 2021. 34 funds tracked by Wall St. Rank hold BNGO as of Q2 2026.

  • Northern Trust held 24,561 shares of Bionano Genomics worth $27.8K as of Q2 2026.
  • Northern Trust bought 4,042 Bionano Genomics shares in Q2 2026, an estimated $4.87K.
  • Bionano Genomics made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #4341 holding.
  • Northern Trust first reported a position in Bionano Genomics in Q4 2019 and has held it in 24 quarters since.
  • Northern Trust's Bionano Genomics position peaked at $15.1M in Q3 2021.
  • 34 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.